Presentation Information

[O17-04]An Interim report of 50 cases of post-marketing surveillance of Lisdexamfetamine in pediatric ADHD.

Ryoko Otani1,2, Takeshi Inoue1, Nozomi Omori1, Naho Matsushima1, Ryoichi Sakuta1 (1.Child Development and Psychosomatic Medical Center, Saitama, Japan, 2.Oji clinic)

Password required to view